Unknown

Dataset Information

0

Vaccination Prevented Short-Term Memory Loss, but Deteriorated Long-Term Spatial Memory in Alzheimer's Disease Mice, Independent of Amyloid-? Pathology.


ABSTRACT: Background:Soluble oligomeric amyloid-? (A?), rather than A? plaques, seems to be the culprit in Alzheimer's disease (AD). Accordingly, a new concept vaccine of small cyclic peptide conjugates, selectively targeting oligomeric A?, has been developed. Objective:Study the therapeutic potential of this new vaccine in a mouse model for AD. Methods:J20 mice, overexpressing human amyloid precursor protein, were validated for an AD-like phenotype. Then, J20 mice were vaccinated at 2, 3, and 4 months of age and AD phenotype was evaluated at 6, 9, and 12 months of age; or at 9, 10, and 11 months with evaluation at 12 months. Effects on A? pathology were studied by plaque load (immunohistochemistry; 6E10) and antibody titers against A? (ELISA). AD behavioral phenotype was evaluated by performance in a battery of cognitive tests. Results:J20 mice displayed age-related A? plaque development and an AD-like behavioral phenotype. A consistent antibody response to the cyclic peptides was, however, not extended to A?, leaving plaque load unaffected. Nevertheless, immunization at young ages prevented working- and short-term spatial memory loss, but deteriorated long-term spatial learning and memory, at 12 months of age. Immunization at later ages did not affect any measured parameter. Conclusion:J20 mice provide a relevant model for AD to study potential anti-A? treatment. Early vaccination prevented short-term memory loss at later ages, but deteriorated long-term spatial memory, however without affecting A? pathology. Later vaccination had no effects, but optimal timing may require further investigation.

SUBMITTER: Oberman K 

PROVIDER: S-EPMC7458552 | biostudies-literature | 2020 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Vaccination Prevented Short-Term Memory Loss, but Deteriorated Long-Term Spatial Memory in Alzheimer's Disease Mice, Independent of Amyloid-β Pathology.

Oberman Klaske K   Gouweleeuw Leonie L   Hoogerhout Peter P   Eisel Ulrich L M ULM   van Riet Elly E   Schoemaker Regien G RG  

Journal of Alzheimer's disease reports 20200723 1


<h4>Background</h4>Soluble oligomeric amyloid-β (Aβ), rather than Aβ plaques, seems to be the culprit in Alzheimer's disease (AD). Accordingly, a new concept vaccine of small cyclic peptide conjugates, selectively targeting oligomeric Aβ, has been developed.<h4>Objective</h4>Study the therapeutic potential of this new vaccine in a mouse model for AD.<h4>Methods</h4>J20 mice, overexpressing human amyloid precursor protein, were validated for an AD-like phenotype. Then, J20 mice were vaccinated at  ...[more]

Similar Datasets

| S-EPMC8110255 | biostudies-literature
| S-EPMC3085505 | biostudies-other
| S-EPMC4865502 | biostudies-literature
| S-EPMC5684335 | biostudies-literature
| S-EPMC1800308 | biostudies-literature
| S-EPMC6580312 | biostudies-literature
| S-EPMC2856604 | biostudies-literature
| S-EPMC8589962 | biostudies-literature
2022-10-14 | PXD035933 | Pride
| S-EPMC5363269 | biostudies-literature